𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma

✍ Scribed by Yoshikawa, D; Ojima, H; Kokubu, A; Ochiya, T; Kasai, S; Hirohashi, S; Shibata, T


Book ID
109999995
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
422 KB
Volume
100
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.